SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-24-010985
Filing Date
2024-04-04
Accepted
2024-04-04 06:05:42
Documents
11
Period of Report
2024-05-22

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A dmtp20240329_def14a.htm DEF 14A 1288298
2 compactgrph.jpg GRAPHIC 21497
3 image01.jpg GRAPHIC 14110
4 image02.jpg GRAPHIC 11854
5 image03.jpg GRAPHIC 4004
6 image04.jpg GRAPHIC 5072
7 image05.jpg GRAPHIC 6253
8 image06.jpg GRAPHIC 20807
9 image07.jpg GRAPHIC 57414
10 pc01.jpg GRAPHIC 104341
11 pc02.jpg GRAPHIC 95844
  Complete submission text file 0001437749-24-010985.txt   1760488
Mailing Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305
Business Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305 (763) 496-5454
DiaMedica Therapeutics Inc. (Filer) CIK: 0001401040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36291 | Film No.: 24821542
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)